144 related articles for article (PubMed ID: 9888524)
1. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
3. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of T-type Ca2+ channels by Ro 40-5967.
Mishra SK; Hermsmeyer K
Circ Res; 1994 Jul; 75(1):144-8. PubMed ID: 8013072
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
Triggle DJ
J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
[TBL] [Abstract][Full Text] [Related]
7. T- and L-type Ca2+-channel antagonists reduce contractility in guinea pig cardiac myocytes.
Hoischen S; Brixius K; Schwinger RH
J Cardiovasc Pharmacol; 1998 Aug; 32(2):323-30. PubMed ID: 9700997
[TBL] [Abstract][Full Text] [Related]
8. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
Lijnen P; Fagard R; Petrov V
J Cardiovasc Pharmacol; 1999 Apr; 33(4):595-604. PubMed ID: 10218730
[TBL] [Abstract][Full Text] [Related]
9. Proliferation of human peripheral blood mononuclear cells during calcium channel blockade.
Lijnen P; Fagard R; Petrov V
Am J Hypertens; 1998 Dec; 11(12):1461-8. PubMed ID: 9880128
[TBL] [Abstract][Full Text] [Related]
10. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
[TBL] [Abstract][Full Text] [Related]
11. Mibefradil (Ro 40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts.
Liu JH; Bijlenga P; Occhiodoro T; Fischer-Lougheed J; Bader CR; Bernheim L
Br J Pharmacol; 1999 Jan; 126(1):245-50. PubMed ID: 10051142
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.
Cribbs LL; Lee JH; Yang J; Satin J; Zhang Y; Daud A; Barclay J; Williamson MP; Fox M; Rees M; Perez-Reyes E
Circ Res; 1998 Jul; 83(1):103-9. PubMed ID: 9670923
[TBL] [Abstract][Full Text] [Related]
13. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels.
Randall AD; Tsien RW
Neuropharmacology; 1997 Jul; 36(7):879-93. PubMed ID: 9257934
[TBL] [Abstract][Full Text] [Related]
14. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Mehrke G; Zong XG; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Bian K; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
[TBL] [Abstract][Full Text] [Related]
16. Voltage-dependent Ca2+ currents contribute to spontaneous Ca2+ waves in rabbit corpus cavernosum myocytes.
McCloskey C; Cagney V; Large R; Hollywood M; Sergeant G; McHale N; Thornbury K
J Sex Med; 2009 Nov; 6(11):3019-31. PubMed ID: 19694931
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs.
van der Lee R; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764
[TBL] [Abstract][Full Text] [Related]
18. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons.
McDonough SI; Bean BP
Mol Pharmacol; 1998 Dec; 54(6):1080-7. PubMed ID: 9855637
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Cremers B; Flesch M; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells.
Arnoult C; Villaz M; Florman HM
Mol Pharmacol; 1998 Jun; 53(6):1104-11. PubMed ID: 9614215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
